213 related articles for article (PubMed ID: 19114027)
1. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
[TBL] [Abstract][Full Text] [Related]
2. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
3. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
Giannico G; Cortes P; Baccora MH; Hassett C; Taube DW; Yee J
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F57-65. PubMed ID: 16896180
[TBL] [Abstract][Full Text] [Related]
7. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
[TBL] [Abstract][Full Text] [Related]
8. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.
Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC
J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
10. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
[TBL] [Abstract][Full Text] [Related]
11. [Effect of shenkangwan on TGF-beta1 and FN in rat mesangial cells cultured by high glucose].
Xiao W; Ma Y; Wei LB
Zhong Yao Cai; 2006 Sep; 29(9):924-7. PubMed ID: 17212050
[TBL] [Abstract][Full Text] [Related]
12. KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells.
Jung DH; Kim YS; Kim JS
J Ethnopharmacol; 2009 Sep; 125(3):374-9. PubMed ID: 19666101
[TBL] [Abstract][Full Text] [Related]
13. Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells.
Wang JY; Yin XX; Wu YM; Tang DQ; Gao YY; Wan MR; Hou XY; Zhang B
Acta Pharmacol Sin; 2006 Sep; 27(9):1222-30. PubMed ID: 16923344
[TBL] [Abstract][Full Text] [Related]
14. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
[TBL] [Abstract][Full Text] [Related]
15. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
McGaha TL; Phelps RG; Spiera H; Bona C
J Invest Dermatol; 2002 Mar; 118(3):461-70. PubMed ID: 11874485
[TBL] [Abstract][Full Text] [Related]
16. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
Ji L; Yin XX; Wu ZM; Wang JY; Lu Q; Gao YY
Phytother Res; 2009 Apr; 23(4):477-85. PubMed ID: 19003945
[TBL] [Abstract][Full Text] [Related]
18. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt DP; Libermann TA; Pines M
Cell Tissue Res; 2007 Apr; 328(1):153-66. PubMed ID: 17180598
[TBL] [Abstract][Full Text] [Related]
19. L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-β production and signalling.
Köppel H; Riedl E; Braunagel M; Sauerhoefer S; Ehnert S; Godoy P; Sternik P; Dooley S; Yard BA
Nephrol Dial Transplant; 2011 Dec; 26(12):3852-8. PubMed ID: 21750159
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]